Managing Diabetes at Different Stages of Life Tags Coronary artery disease DPP-4 inhibitors Read more about Managing Diabetes at Different Stages of Life
Evidence to Experience while Choosing DPP4i Tags DPP-4 inhibitors Read more about Evidence to Experience while Choosing DPP4i
DPP4i: A Trusted Companion for a Broad Range of Patients with T2DM with special Focus on Sitagliptin Tags DPP-4 inhibitors Read more about DPP4i: A Trusted Companion for a Broad Range of Patients with T2DM with special Focus on Sitagliptin
GLP-1 Therapies Lower Major Limb Events in PAD Tags Coronary artery disease Peripheral vascular disease Myocardial infarction Stroke GLP-1 agonists Read more about GLP-1 Therapies Lower Major Limb Events in PAD
Early CKM Patients on Tirzepatide Had Fewer CV Events Tags Peripheral vascular disease Coronary artery disease GLP-1 agonists Read more about Early CKM Patients on Tirzepatide Had Fewer CV Events
Semaglutide Shows Strong HbA1c, Weight Effects in Young T2DM Adults Tags hBA1c GLP-1 agonists Read more about Semaglutide Shows Strong HbA1c, Weight Effects in Young T2DM Adults
GLP-1 Therapy Shows Fewer Parkinson Disease Cases Than Sulfonylureas Tags Sulphonylureas GLP-1 agonists Read more about GLP-1 Therapy Shows Fewer Parkinson Disease Cases Than Sulfonylureas
Model Maps How Semaglutide May Drive Weight and Glucose Control Tags GLP-1 agonists Read more about Model Maps How Semaglutide May Drive Weight and Glucose Control
Triple FDC Improved HbA1c More Than Dual Therapies in T2DM Tags hBA1c Sulphonylureas Biguanide α-Glucosidase inhibitors Read more about Triple FDC Improved HbA1c More Than Dual Therapies in T2DM
Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM Tags GLP-1 agonists Read more about Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM